Key result
18F-FDG PET/CT successfully detects occult LV metastasis in a patient with malignant melanoma.
Why the study?
Does 18F-FDG PET/CT detect occult cardiac metastases in patients with malignant melanoma?
Case Report (n=1)
Does 18F-FDG PET/CT detect occult cardiac metastases in patients with malignant melanoma?
18F-FDG PET/CT is an effective imaging modality for detecting occult cardiac metastases in patients with malignant melanoma.
May aid detection in select melanoma cases; leaves open need for prospective validation before broader use.
A 63-year-old man with a history of right plantar malignant melanoma (T3bN0M0, IIb) developed multiple metastases in bilateral lungs 19 months after surgery. Subsequent 18F-FDG PET/CT revealed multiple pulmonary metastases with intense FDG uptake and detected a hypermetabolic lesion in the lateral wall of the left ventricle, which was considered to be a cardiac metastasis of malignant melanoma. This lesion was later confirmed in the dynamic myocardial perfusion MR. This case demonstrates the effectiveness of 18F-FDG PET/CT in detecting occult cardiac metastases of malignant melanoma.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a case report in Cardiac metastasis of malignant melanoma (n=1). 18F-FDG PET/CT was evaluated on Detection of occult cardiac metastases. 18F-FDG PET/CT successfully detected an occult cardiac metastasis in the left ventricle of a 63-year-old man with malignant melanoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: